Nephrodite, Inc.
PrivateLast Round
Series A
Apr 1, 2023
Total Funding Raised
$1.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nephrodite, Inc. operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was an Accelerator round in June 2022.
Nephrodite, Inc. is a medical device company that develops implantable, continuous renal replacement systems for patients with end-stage kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nephrodite, Inc. Comparables
Compare Nephrodite, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| US Kidney Research Corporation | 87% | |
| Qidni Labs | 83% | |
| Wearable Artificial Organs, Inc. | 79% |
For institutional investors. Book with your work email.
Nephrodite, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2023 | ||||
| Accelerator | Jun 24, 2022 | ||||
| Accelerator | Jul 30, 2020 |
For institutional investors. Book with your work email.
Nephrodite, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| Austin Technology Incubator | Accelerator |
| Bundesregierung | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 222% MoM, reaching 3.2K.
- Apr 9, 2026
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
Nephrodite, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nephrodite, Inc.'s valuation, stock price, and market status.
Is Nephrodite, Inc. a public or private company?
Nephrodite, Inc. is a private company.
What is the current stock price of Nephrodite, Inc.?
Nephrodite, Inc. is a private company, so its shares have no public market price. Caplight tracks Nephrodite, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nephrodite, Inc. worth (valuation)?
Valuation information for Nephrodite, Inc. is not publicly available.
Can I buy Nephrodite, Inc. stock?
Nephrodite, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nephrodite, Inc.'s last funding round?
Nephrodite, Inc.'s most recent funding round was Series A on April 1, 2023.
Who are the main investors in Nephrodite, Inc.?
Key investors in Nephrodite, Inc. include Creative Destruction Lab, Austin Technology Incubator, Bundesregierung.
Will Nephrodite, Inc. IPO soon?
No public IPO plans have been announced for Nephrodite, Inc..
How can I track Nephrodite, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nephrodite, Inc.'s shares on secondary markets.